Welcome to our dedicated page for Lifevantage SEC filings (Ticker: LFVN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Searching for LifeVantage Corp’s latest consultant counts or product-line revenue without wading through dense text? Investors typically arrive here asking, “Where can I find LifeVantage’s quarterly earnings report 10-Q filing?” or “How do I track LifeVantage insider trading Form 4 transactions in real time?” This page bundles every SEC disclosure so you no longer jump between scattered EDGAR links.
Stock Titan’s AI reads each LifeVantage 8-K, 10-Q, and 10-K the moment it posts, then delivers plain-English summaries that flag shifts in independent-consultant enrollment, inventory risk and regulatory updates around nutrigenomic claims. Instead of skimming 200-plus pages, you’ll see the numbers that shape margins—net sales by product family, commission expense trends and emerging compliance issues—explained simply.
Use our quick-access tiles to drill into:
- Annual report 10-K simplified – pick out segment revenue, R&D on nutrigenomics and direct-sales compensation disclosures in minutes.
- Quarterly earnings report 10-Q – monitor consultant turnover, inventory levels and cash flow each quarter with AI-annotated highlights.
- Form 4 insider transactions – real-time alerts on LifeVantage executive stock moves so you can spot buying or selling trends fast.
- 8-K material events explained – leadership changes, product-safety notices or distributor policy updates distilled into key takeaways.
- Proxy statement executive compensation – understand how bonuses tie to enrolment growth and nutrigenomic product launches.
Whether you’re comparing quarters, dissecting compensation plans, or simply trying to “understand LifeVantage SEC documents with AI,” this hub keeps every filing current and comprehensible. Save hours, gain clarity, and turn regulatory disclosures into actionable insight.
LifeVantage Corp. (LFVN) has filed a Form 4 disclosing that its President & CEO, Steven R. Fife, disposed of 21,064 common shares on 07/01/2025. The transaction is coded “F,” signifying shares were withheld to satisfy tax or exercise-price obligations under Rule 16b-3. The shares were valued at $13.39 each, equating to an aggregate market value of roughly $282 thousand. After this withholding event, Fife’s direct ownership stands at 611,307 shares. No derivative security transactions were reported, and no other insiders were listed on this filing.
LifeVantage Corp. (LFVN) has filed a Form 4 disclosing that its President & CEO, Steven R. Fife, disposed of 21,064 common shares on 07/01/2025. The transaction is coded “F,” signifying shares were withheld to satisfy tax or exercise-price obligations under Rule 16b-3. The shares were valued at $13.39 each, equating to an aggregate market value of roughly $282 thousand. After this withholding event, Fife’s direct ownership stands at 611,307 shares. No derivative security transactions were reported, and no other insiders were listed on this filing.
LifeVantage Corporation (LFVN) Chief Marketing Officer Julie Boyster filed a Form 4 covering transactions on 1 July 2025.
- 3,667 shares acquired through the conversion (code M) of previously granted performance restricted stock units (PSUs) at a $0 exercise price.
- 3,970 shares disposed (code F) to cover statutory tax withholding at $13.39 per share.
- Post-transaction, Boyster directly owns 115,214 common shares; all PSUs from the 2022 grant have now been converted.
- The 2022 PSU grant paid out at 133.13 % of target, indicating the company exceeded the preset performance criteria.
The net effect is a modest reduction of 303 shares (-0.3 % of her holdings). Because both events are routine vesting and tax-withholding activities, they carry limited market impact but do confirm above-target performance achievement for the FY-2022 incentive metrics.
LifeVantage Corporation (LFVN) Chief Marketing Officer Julie Boyster filed a Form 4 covering transactions on 1 July 2025.
- 3,667 shares acquired through the conversion (code M) of previously granted performance restricted stock units (PSUs) at a $0 exercise price.
- 3,970 shares disposed (code F) to cover statutory tax withholding at $13.39 per share.
- Post-transaction, Boyster directly owns 115,214 common shares; all PSUs from the 2022 grant have now been converted.
- The 2022 PSU grant paid out at 133.13 % of target, indicating the company exceeded the preset performance criteria.
The net effect is a modest reduction of 303 shares (-0.3 % of her holdings). Because both events are routine vesting and tax-withholding activities, they carry limited market impact but do confirm above-target performance achievement for the FY-2022 incentive metrics.
LifeVantage Corporation (LFVN) Chief Marketing Officer Julie Boyster filed a Form 4 covering transactions on 1 July 2025.
- 3,667 shares acquired through the conversion (code M) of previously granted performance restricted stock units (PSUs) at a $0 exercise price.
- 3,970 shares disposed (code F) to cover statutory tax withholding at $13.39 per share.
- Post-transaction, Boyster directly owns 115,214 common shares; all PSUs from the 2022 grant have now been converted.
- The 2022 PSU grant paid out at 133.13 % of target, indicating the company exceeded the preset performance criteria.
The net effect is a modest reduction of 303 shares (-0.3 % of her holdings). Because both events are routine vesting and tax-withholding activities, they carry limited market impact but do confirm above-target performance achievement for the FY-2022 incentive metrics.
FAQ
What is the current stock price of Lifevantage (LFVN)?
What is the market cap of Lifevantage (LFVN)?
What is the core business of LifeVantage Corp?
How does LifeVantage incorporate nutrigenomics into its products?
What product categories does LifeVantage offer?
How does the independent consultant model work for LifeVantage?
In what ways is LifeVantage distinguished from other nutraceutical companies?
What makes LifeVantage's weight management solutions unique?
